It is unknown whether myoclonic epilepsy is related to altered BSLC2 expression in the brain; however, the improvement in myoclonic seizures following the introduction of metreleptin may suggest a contributory role for leptin deficiency in neurodegeneration (70). The gene discussed is LEP; the disease is myoclonic epilepsy.